Association between smoking and minimal-mild depressive symptomatology in heavy smokers

Salud Mental

Volumn 32, Issue 3, 2009, Pages 199-204

  Coutiño, Ana Moreno ^a   Velasco, Silvia Ruiz ^b   Icaza, María Elena Medina Mora ^c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b IIMAS UNAM   (Mexico)

^c INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

Author keywords

Depression; Smoking; Sociodemographic characteristics

Indexed keywords

EID: 77952131001     PISSN: 01853325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. th 2008] Available at: http://www.who.int/healthinfo/global_burden_disease/en/index.html
2. Secretaría de Salud, Instituto Nacional de Estadística, Geografía e Informática. Encuesta Nacional de Adicciones 2002. México, DF: Consejo Nacional de Adicciones; 2002.
3. Secretaría de Salud. Plan Nacional de Salud 2001-2006. México, DF: Secretaría de Salud; 2001.
4. Secretaría de Salud. Programa específico de depresión. México, DF: Servicios de Salud Mental; 2002.
5. Medina-Mora ME, Borges G, Lara C, Benjet C, Blanco J et al. Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey. Psychol Med 2005;35:1773-1783.
6. Breslau N, Kilbey M, Andreski P. Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiological study of young adults. Am J Psychiatry 1992;149:464-469.
7. Breslau N, Kilbey M, Andreski P. Nicotine dependence and major depression: new evidence from a prospective investigation. Arch Gen Psychiatry 1993;50:31-35.
8. Breslau N, Novak SP, Kessler RC. Psychiatric disorders and stages of smoking. Biol Psychiatry 2004;55:69-76.
9. Glassman A, Helzer JE, Covey LS. Smoking, smoking cessation and major depression. JAMA 1990;264:1546-1594.
10. Stage KB, Glassman AH, Covey LS. Depression after smoking cessation: case reports. J Clin Psychiatry 1996;57:467-469.
11. Lyons M, Hitsman B, Xian H, Panizzon MS, Jerskey BA et al. A twin study of smoking, nicotine dependance, and major depression in men. Nicotine Tob Res 2008;10:97-108.
12. Wiesbeck GA, Kuhl HC, Yaldizili O, Wurst FM. Tobacco smoking and depresiónresults from the WHO/ISBRA study, Neuropsychobiology 2008;57:26-31.
13. Glassman A, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet 2001;357:1929-1932.
14. Munafò MR, Hitsman B, Rende R, Metcalfe C, Niaura R. Effects of progression to cigarette smoking on depressed mood in adolescents: evidence from the National Longitudinal Study of Adolescent Health. Addiction 2008;103:162-171.
15. Medina-Mora ME, Borges G, Lara C, Benjet C. La salud mental en México y los retos para su atención. Resultados de la Encuesta Nacional de Epidemiología Psiquiátrica. Manual de Trastornos Mentales. México: Asociación Psiquiátrica Mexicana AC; 2006.
16. Benjet C, Borges GG, Medina-Mora ME, Fleiz-Bautista C, Zambrano-Ruiz J. La depresión con inicio temprano: prevalencia, curso natural y latencia para buscar tratamiento. Salud Publica Mex 2004;46(5):17-24.
17. Foulds J, Steinberg MB, Williams JM, Ziedonis DM. Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev 2008;25:59-71.
18. Saxon AJ, Baer JS, Davis TM, Sloan KL, Malte CA et al. Smoking cessation treatment among dually diagnosed individuals: preliminary evaluation of different pharcotherapies. Nicotine Tob Res 2003;5(4):589-596.
19. Lai I, Hong Ch, Tsai S. Association study of nicotinic-receptor variants and major depressive disorder. J Affect Disord 2001;66:79-82.
20. Pomerleau CS. Co-factors for smoking and evolutionary psychobiology. Addiction 1997;92(4):397-408.
21. Salín-Pascual R, de la Fuente JR, Galicia-Polo L, Drucker-Colín R. Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology 1995;121:476-479.
22. Salín-Pascual R, Drucker-Colín R. A novel effect of nicotine on mood and sleep in major depression. Neuroreport 1998;9:57-60.
23. Moreno-Coutiño A, Calderón-Ezquerro C, Drucker-Colín R. Long term changes in sleep and depressive symptoms of smokers in abstinente. Nicotine Tob Res 2007;9:389-396.
24. Catley D, Harris KJ, Okuyemi KS, Mayo MS, Pankey E et al. The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion. Nicotine Tob Res 2005;7:859-870.
25. Haug NA, Hall SM, Prochaska JJ. Acceptance of nicotine dependence treatment among currently depressed smokers. Nicotine Tob Res 2005;7:217-224.
26. Mihailescu S, Drucker-Colín R. Nicotine, brain nicotinic receptors, and neuropsychiatric disorders. Arch Med Res 2000;31:131-144.
27. Aveyard P, Johnson C, Fillingham S, Parsons A, Murphy M. Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomized controlled trial. Br Med J 2008;336:1223-1227.
28. Glover ED, Glover PN. Pharmacologic treatments for the nicotine dependent smoker. Am J Health Behav 2001;25(3):179-182.
29. Hitsman B, Pingitore R, Spring B, Mahableshwarkar A, Mizes JS et al. Antidepressant pharmacotherapy helps some cigarette smokers more than others. J Consult Clin Psychol 1999;67:547-554.
30. Hughes JR. Depression during tobacco abstinence. Nicotine Tob Res 2007;9:443-446.
31. Hurt RD, Sachs DP, Glover ED, Offord KP, Johnston JA, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 1997;337:1195-1202.
32. Lerman C, Niaura R, Collins BN. Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychol Addict Behav 2004;18:362-366.
33. Heatherton T, Kozlowski L, Frecker R, Fagerström K. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnarie. Br J Adict 1991;86:1119-1127.
34. Jurado S, Villegas ME, Méndez L, Rodríguez F, Loperena V et al. La estandarización del Inventario de Depresión de Beck para los residentes de la Ciudad de México. Salud Mental 1998;21:26-31.
35. Beck, CT, Froman RD, Bernal H. Acculturation level and postpartum depression in Hispanic mothers. Am J Matern Child Nurs 2005;30:299-204.
36. Becoña E, Vázquez FL. The Fargestrom Test for Nicotine Dependence in a Spanish sample. Psychol Rep 1998;83:1455-1458.
37. Esquivel-Molina CG, Buendía-Cano F, Martínez-García O, Martínez-Mendoza JA, Martínez-Ordaz VA et al. Burnout syndrome in medical staff affiliated to a tertiary care hospital. Rev Med Inst Mex Seguro Soc 2007;45:427-436.
38. Lara-Rivas G, Ramírez-Venegas A, Sansores-Martínez R, Espinoza A, Regalado J. Indicadores de síntomas de abstinencia en un grupo de fumadores mexicanos. Salud Publica Mex 2007;49:257-262.
39. Salín-Pascual RJ, Basañes-Villa E. Changes in compulsion and anxiety symptoms with nicotine transdermal patches in non-smoking obsessive-compulsive disorder patients. Rev Invest Clin 2003;55:650-654.
40. Hutchinson J, Tizabi Y, Taylor R. Rapid method for the simultaneous measurement of nicotine and continine in urine and serum by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1998;708:87-93.
41. Benjet C, Wagner FA, Borges GG, Medina-Mora ME. The relationship of tobacco smoking with depressive symptomatology in the Third Mexican National Addictions Survey. Psychol Med 2004;34(5):881-888.
42. Cavelaars AE, Kunst AE, Geurts JJ, Crialesi R, Grötvedt L, et al. Educational differences in smoking: International comparison. Br Med J 2000;320:1102-1107.
43. Ochoa A, Enamorado N. Incidencia de pacientes fumadores en un grupo poblacional. Rev Cubana Enferm 2004;20(3) [Consult October 3th 2008] Available at: http://scieloprueba.sld.cu
44. Okuyemi KS, Ahluwalia JS, Harris KJ. Pharmacotherapy of smoking cessation. Arch Fam Med 2000;9:270-281.
45. Cornuz J, Pinget C, Gilbert A, Paccaud F. Cost-effectiveness analysis of the first-line therapies for nicotine dependence. Eur J Cli Pharmacol 2003;59(3):201-206.
46. Cornuz J, Gilbert A, Pinget C, McDonald P, Slama K et al. Cost-effectiveness of pharmacotherapies for nicotine dependence in primary care settings: a multinational comparison. Tob Control 2006;15:152-159.
47. Covey LS, Glassman AH, Stetner F. Cigarette smoking and major depression. J Addic Dis 1998;17:35-46.
48. Durcan MJ, White J, Jorenby DE, Fiore MC, Rennard SI et al. Impact of prior nicotine replacement therapy on smoking cessation efficacy. Am J Health Behav 2002;26(3):213-20.
49. Etter JF, Stapleton JA. Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tob Control 2006; 15(4):280-285.
50. Fiore MC, Thompson SA, Lawrence DL, Welsch S, Andrews K et al. Helping Wisconsin women quit smoking: a successful collaboration. Wis Med J 2000;99(2):68-72.
51. Thase ME, Haight BR, Richard N, Rockett CB, Mitton M et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry 2005;66(8):974-981.